Published in Neurobiol Dis on April 19, 2005
Mitochondrial oxidative damage in aging and Alzheimer's disease: implications for mitochondrially targeted antioxidant therapeutics. J Biomed Biotechnol (2006) 1.07
Revisiting the Role of Acetylcholinesterase in Alzheimer's Disease: Cross-Talk with P-tau and β-Amyloid. Front Mol Neurosci (2011) 0.97
Multiple faces of dynamin-related protein 1 and its role in Alzheimer's disease pathogenesis. Biochim Biophys Acta (2015) 0.86
Amyloid beta-induced glycogen synthase kinase 3β phosphorylated VDAC1 in Alzheimer's disease: implications for synaptic dysfunction and neuronal damage. Biochim Biophys Acta (2013) 0.84
Hippocampal infusions of apolipoprotein E peptides induce long-lasting cognitive impairment. Brain Res Bull (2009) 0.82
Platelets, a reliable source for peripheral Alzheimer's disease biomarkers? Acta Neuropathol Commun (2014) 0.82
Neuronal AChE splice variants and their non-hydrolytic functions: redefining a target of AChE inhibitors? Br J Pharmacol (2013) 0.82
Platelets and Alzheimer's disease: Potential of APP as a biomarker. World J Psychiatry (2012) 0.81
Sensitivity and specificity of dopamine transporter imaging with 123I-FP-CIT SPECT in dementia with Lewy bodies: a phase III, multicentre study. Lancet Neurol (2007) 3.25
Criteria for the diagnosis of corticobasal degeneration. Neurology (2013) 3.07
Identification of common variants influencing risk of the tauopathy progressive supranuclear palsy. Nat Genet (2011) 2.97
Loss of sight and sound. Could it be the hip? Lancet (2009) 2.43
Clinical and neuroanatomical signatures of tissue pathology in frontotemporal lobar degeneration. Brain (2011) 2.13
Migraine mediates the influence of C677T MTHFR genotypes on ischemic stroke risk with a stroke-subtype effect. Stroke (2007) 2.02
A comparative clinical, pathological, biochemical and genetic study of fused in sarcoma proteinopathies. Brain (2011) 1.89
Heterogeneity of brain glucose metabolism in mild cognitive impairment and clinical progression to Alzheimer disease. Arch Neurol (2005) 1.82
Inherited thrombophilic disorders in young adults with ischemic stroke and patent foramen ovale. Stroke (2003) 1.81
Trigeminal small-fiber sensory neuropathy causes burning mouth syndrome. Pain (2005) 1.73
Regulation of dopamine D1 receptor trafficking and desensitization by oligomerization with glutamate N-methyl-D-aspartate receptors. J Biol Chem (2003) 1.55
A pan-European study of the C9orf72 repeat associated with FTLD: geographic prevalence, genomic instability, and intermediate repeats. Hum Mutat (2013) 1.53
Endothelial nitric oxide synthase (Glu298Asp) polymorphism is an independent risk factor for migraine with aura. Headache (2006) 1.52
Development and assessment of sensitive immuno-PCR assays for the quantification of cerebrospinal fluid three- and four-repeat tau isoforms in tauopathies. J Neurochem (2012) 1.52
Disulfiram neuropathy: two cases of distal axonopathy. Clin Toxicol (Phila) (2008) 1.47
Hyperhomocysteinemia: a potential risk factor for cervical artery dissection following chiropractic manipulation of the cervical spine. J Neurol (2002) 1.44
Evidence of white matter changes on diffusion tensor imaging in frontotemporal dementia. Arch Neurol (2007) 1.42
Outcomes of Alzheimer's disease treatment: the Italian CRONOS project. Int J Geriatr Psychiatry (2003) 1.40
A critical interaction between NR2B and MAGUK in L-DOPA induced dyskinesia. J Neurosci (2006) 1.34
Conversion of amnestic Mild Cognitive Impairment to dementia of Alzheimer type is independent to memory deterioration. Int J Geriatr Psychiatry (2007) 1.34
[alpha]-Secretase ADAM10 as well as [alpha]APPs is reduced in platelets and CSF of Alzheimer disease patients. Mol Med (2002) 1.26
Synaptic activity controls dendritic spine morphology by modulating eEF2-dependent BDNF synthesis. J Neurosci (2010) 1.25
Cerebrospinal fluid Tau/α-synuclein ratio in Parkinson's disease and degenerative dementias. Mov Disord (2011) 1.25
Synapse-associated protein-97 mediates alpha-secretase ADAM10 trafficking and promotes its activity. J Neurosci (2007) 1.23
Efficacy of cognitive rehabilitation in patients with mild cognitive impairment treated with cholinesterase inhibitors. Int J Geriatr Psychiatry (2007) 1.19
Combined 5-HT1A and 5-HT1B receptor agonists for the treatment of L-DOPA-induced dyskinesia. Brain (2008) 1.19
Interleukin-1 beta released by gp120 drives neural death through tyrosine phosphorylation and trafficking of NMDA receptors. J Biol Chem (2006) 1.16
Decreased NR2B subunit synaptic levels cause impaired long-term potentiation but not long-term depression. J Neurosci (2009) 1.16
New targets for pharmacological intervention in the glutamatergic synapse. Eur J Pharmacol (2006) 1.15
Course and management of allogeneic stem cell transplantation in patients with mitochondrial neurogastrointestinal encephalomyopathy. J Neurol (2012) 1.15
Calcium/calmodulin-dependent protein kinase II phosphorylation drives synapse-associated protein 97 into spines. J Biol Chem (2004) 1.13
Thalamic infarcts in young adults: relationship between clinical-topographic features and pathogenesis. Eur Neurol (2002) 1.11
Cumulative effect of predisposing genotypes and their interaction with modifiable factors on the risk of ischemic stroke in young adults. Stroke (2005) 1.11
Reduction in retinal nerve fiber layer thickness in migraine patients. Neurol Sci (2012) 1.10
Neonatal exposure to brominated flame retardant BDE-47 reduces long-term potentiation and postsynaptic protein levels in mouse hippocampus. Environ Health Perspect (2007) 1.09
Atypical phenotypes and clinical variability in a large Italian family with DYT1-primary torsion dystonia. Mov Disord (2006) 1.08
Angiotensin converting enzyme (ACE) inhibitors modulate the rate of progression of amnestic mild cognitive impairment. Int J Geriatr Psychiatry (2006) 1.07
CaMKII-dependent phosphorylation regulates SAP97/NR2A interaction. J Biol Chem (2003) 1.07
Abnormal Ca2+-calmodulin-dependent protein kinase II function mediates synaptic and motor deficits in experimental parkinsonism. J Neurosci (2004) 1.06
Prevalence of patent foramen ovale in a large series of patients with migraine with aura, migraine without aura and cluster headache, and relationship with clinical phenotype. J Headache Pain (2005) 1.06
Pitfalls in diagnosing mitochondrial neurogastrointestinal encephalomyopathy. J Inherit Metab Dis (2011) 1.05
The role of mitochondria in neurodegenerative diseases. J Neurol (2011) 1.05
Neuropathology of mitochondrial diseases. Biosci Rep (2007) 1.05
QT dispersion and heart rate variability abnormalities in Alzheimer's disease and in mild cognitive impairment. J Am Geriatr Soc (2005) 1.04
Misplaced NMDA receptors in epileptogenesis contribute to excitotoxicity. Neurobiol Dis (2011) 1.04
Cerebral amyloid angiopathy-related hemorrhages. Neurol Sci (2008) 1.03
Association between tau H2 haplotype and age at onset in frontotemporal dementia. Arch Neurol (2005) 1.02
Loss of function mutations in the progranulin gene are related to pro-inflammatory cytokine dysregulation in frontotemporal lobar degeneration patients. J Neuroinflammation (2011) 1.02
Epilepsy in glioblastoma multiforme: correlation with glutamine synthetase levels. J Neurooncol (2009) 1.02
Calcium-calmodulin-dependent protein kinase II phosphorylation modulates PSD-95 binding to NMDA receptors. Eur J Neurosci (2006) 1.01
Is frontotemporal lobar degeneration a rare disorder? Evidence from a preliminary study in Brescia county, Italy. J Alzheimers Dis (2010) 1.00
Blood cell markers in Alzheimer Disease: Amyloid Precursor Protein form ratio in platelets. Exp Gerontol (2009) 0.99
White matter changes in corticobasal degeneration syndrome and correlation with limb apraxia. Arch Neurol (2008) 0.99
Acetylcholinesterase inhibitors increase ADAM10 activity by promoting its trafficking in neuroblastoma cell lines. J Neurochem (2004) 0.99
Differential impact of apathy and depression in the development of dementia in mild cognitive impairment patients. Dement Geriatr Cogn Disord (2009) 0.99
Risk of recurrent cerebrovascular events in patients with cryptogenic stroke or transient ischemic attack and patent foramen ovale: the FORI (Foramen Ovale Registro Italiano) study. Cerebrovasc Dis (2010) 0.99
Synaptic localization and activity of ADAM10 regulate excitatory synapses through N-cadherin cleavage. J Neurosci (2010) 0.98
Granulin mutation drives brain damage and reorganization from preclinical to symptomatic FTLD. Neurobiol Aging (2011) 0.98
Distribution of interleukin-1 receptor complex at the synaptic membrane driven by interleukin-1β and NMDA stimulation. J Neuroinflammation (2011) 0.98
Small nerve fiber pathology in critical illness. PLoS One (2013) 0.97
Migraine and ischemic stroke: a debated question. J Cereb Blood Flow Metab (2008) 0.97
Targeting NR2A-containing NMDA receptors reduces L-DOPA-induced dyskinesias. Neurobiol Aging (2011) 0.97
Subcortical and deep cortical atrophy in Frontotemporal Lobar Degeneration. Neurobiol Aging (2009) 0.97
Distinct levels of dopamine denervation differentially alter striatal synaptic plasticity and NMDA receptor subunit composition. J Neurosci (2010) 0.97
Mechanisms underlying the impairment of hippocampal long-term potentiation and memory in experimental Parkinson's disease. Brain (2012) 0.96
Effects of central and peripheral inflammation on hippocampal synaptic plasticity. Neurobiol Dis (2013) 0.96
Systemic thrombolysis in patients with acute ischemic stroke and Internal Carotid ARtery Occlusion: the ICARO study. Stroke (2011) 0.96
Homocysteine and cerebral ischemia: pathogenic and therapeutical implications. Curr Med Chem (2007) 0.95
NR2B subunit exerts a critical role in postischemic synaptic plasticity. Stroke (2006) 0.95
SAP97 directs the localization of Kv4.2 to spines in hippocampal neurons: regulation by CaMKII. J Biol Chem (2007) 0.95
Synaptic dysfunction in Alzheimer's disease. Adv Exp Med Biol (2012) 0.94
Changes of peripheral A2A adenosine receptors in chronic heart failure and cardiac transplantation. FASEB J (2002) 0.94
Epilepsy in cerebral glioma: timing of appearance and histological correlations. J Neurooncol (2009) 0.94